ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,872 | -42.7% | 4,784 | -35.2% | 0.00% | -40.0% |
| Q2 2023 | $149,847 | +210952.1% | 7,378 | +89.8% | 0.01% | +150.0% |
| Q1 2023 | $71 | -51.7% | 3,888 | -45.5% | 0.00% | -66.7% |
| Q4 2022 | $147 | -99.9% | 7,134 | +61.3% | 0.01% | +200.0% |
| Q3 2022 | $115,000 | -65.0% | 4,424 | -65.9% | 0.00% | -71.4% |
| Q2 2022 | $329,000 | +306.2% | 12,974 | +409.6% | 0.01% | +600.0% |
| Q1 2022 | $81,000 | -56.5% | 2,546 | -44.6% | 0.00% | -66.7% |
| Q4 2021 | $186,000 | -29.3% | 4,596 | -39.1% | 0.00% | -57.1% |
| Q3 2021 | $263,000 | +105.5% | 7,551 | +63.1% | 0.01% | +133.3% |
| Q2 2021 | $128,000 | -2.3% | 4,629 | -1.0% | 0.00% | +50.0% |
| Q1 2021 | $131,000 | +156.9% | 4,675 | +136.6% | 0.00% | 0.0% |
| Q4 2020 | $51,000 | -57.1% | 1,976 | -71.6% | 0.00% | +100.0% |
| Q3 2020 | $119,000 | -76.7% | 6,968 | -66.2% | 0.00% | -95.2% |
| Q2 2020 | $510,000 | +5000.0% | 20,619 | +1860.0% | 0.02% | +2000.0% |
| Q3 2019 | $10,000 | -83.6% | 1,052 | -78.4% | 0.00% | -75.0% |
| Q1 2019 | $61,000 | +6000.0% | 4,870 | +8596.4% | 0.00% | – |
| Q3 2018 | $1,000 | -96.3% | 56 | -97.5% | 0.00% | -100.0% |
| Q2 2018 | $27,000 | – | 2,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |